Ertapenem – Injection products
Recognized Interpretive Criteria
Additional FDA-identified interpretive criteria
| Minimum Inhibitory | Disk Diffusion | ||||
---|---|---|---|---|---|---|
Pathogen | S | I | R | S | I | R |
Enterobacteriaceae | M100 standard is recognized | |||||
Staphylococcus spp.a | ≤2 | 4 | ≥8 | ≥19 | 16-18 | ≤15 |
Haemophilus influenzae and | M100 standard is recognized | |||||
Streptococcus pneumoniae | M100 standard is recognized | - | - | - | ||
Streptococcus spp β- | M100 standard is recognized | - | - | - | ||
Streptococcus spp Viridans | M100 standard is recognized | - | - | - | ||
Anaerobes | M100 standard is recognized | - | - | - |
S = Susceptible; I = Intermediate; R = Resistant
a The standard regarding surrogate testing is recognized.